PL2608802T3 - Immunoterapeutyczny sposób leczenia raka gruczołu krokowego - Google Patents

Immunoterapeutyczny sposób leczenia raka gruczołu krokowego

Info

Publication number
PL2608802T3
PL2608802T3 PL11751668T PL11751668T PL2608802T3 PL 2608802 T3 PL2608802 T3 PL 2608802T3 PL 11751668 T PL11751668 T PL 11751668T PL 11751668 T PL11751668 T PL 11751668T PL 2608802 T3 PL2608802 T3 PL 2608802T3
Authority
PL
Poland
Prior art keywords
prostate cancer
treating prostate
immunotherapeutic method
immunotherapeutic
treating
Prior art date
Application number
PL11751668T
Other languages
English (en)
Inventor
Bennink Herman Jan Tijmen Coelingh
Original Assignee
Pantarhei Bioscience B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantarhei Bioscience B.V. filed Critical Pantarhei Bioscience B.V.
Publication of PL2608802T3 publication Critical patent/PL2608802T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/884—Vaccine for a specifically defined cancer prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11751668T 2010-08-27 2011-08-29 Immunoterapeutyczny sposób leczenia raka gruczołu krokowego PL2608802T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10174349 2010-08-27
EP11751668.2A EP2608802B1 (en) 2010-08-27 2011-08-29 Immunotherapeutic method for treating prostate cancer

Publications (1)

Publication Number Publication Date
PL2608802T3 true PL2608802T3 (pl) 2017-08-31

Family

ID=44543718

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11751668T PL2608802T3 (pl) 2010-08-27 2011-08-29 Immunoterapeutyczny sposób leczenia raka gruczołu krokowego

Country Status (9)

Country Link
US (1) US9295720B2 (pl)
EP (1) EP2608802B1 (pl)
CN (1) CN103179977B (pl)
BR (1) BR112013004389A2 (pl)
CA (1) CA2809153C (pl)
ES (1) ES2621806T3 (pl)
PL (1) PL2608802T3 (pl)
RU (1) RU2586774C2 (pl)
WO (1) WO2012026820A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016080830A2 (en) * 2014-11-18 2016-05-26 Pantarhei Bioscience B.V. Immunotherapeutic method for treating pancreatic cancer
CA3080835A1 (en) * 2017-10-31 2019-05-09 Pantarhei Bioscience B.V. Immunotherapeutic methods for treating and/or preventing lung cancer
WO2023066923A1 (en) 2021-10-19 2023-04-27 Rahman Nafis Male contraception

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328470A (en) 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5641487A (en) * 1989-06-12 1997-06-24 The Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
US5272070A (en) 1991-03-08 1993-12-21 Board Of Regents, The University Of Texas System Method for the preparation of cell lines producing Man3 GlcNac 2 asparagine-linked gylcans and cell lines produced thereby
US5789543A (en) 1993-12-30 1998-08-04 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing proteins and uses related thereto
AU763247C (en) 1998-02-19 2005-05-19 Eastern Virginia Medical School Recombinant active human zona pellucida protein 3 (hZP3)
FR2777890B1 (fr) 1998-04-22 2000-12-29 Roussy Inst Gustave Composes peptidiques d'hsp70 utiles dans l'immunotherapie du cancer
ATE304375T1 (de) 1998-05-23 2005-09-15 Univ Leiden Medical Ct Cd40 bindende antikörper und ctl peptide zur behandlung von tumoren
EP0978285B1 (en) 1998-08-07 2005-11-23 F. Hoffmann-La Roche Ag Stable pharmaceutical composition of hedgehog proteins and use thereof.
US6455041B1 (en) * 1998-11-17 2002-09-24 Bonita S. Dunbar Immunogenic epitopes of the human zona pellucida protein (ZP1)
US6359196B1 (en) 1999-09-23 2002-03-19 Finn Lok Germination-specific plant promoters
DE60132169T2 (de) 2000-01-31 2008-12-11 Pharming Intellectual Property Bv Humaner c1 inhibitor hergestellt in der milch transgener säugetiere
AU2001288231A1 (en) * 2000-08-04 2002-02-18 Zymogenetics Inc. Human secreted protein, zzp1
US7202034B2 (en) 2000-12-08 2007-04-10 Academisch Ziekenhuis Leiden Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
EP1543039B1 (en) * 2002-08-12 2011-07-13 The Council Of The Queensland Institute Of Medical Research Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes
PL1618128T3 (pl) 2003-04-23 2010-12-31 Max Planck Gesellschaft Szczepionka przeciwko gruźlicy o ulepszonej skuteczności
AR056245A1 (es) 2003-06-19 2007-10-03 Bestewil Holding Bv Membranas virales reconstituidas funcionales que contienen un coadyuvante
CA2630175C (en) * 2005-11-16 2018-10-23 Pantarhei Bioscience B.V. Immunotherapeutic method for treating and/or preventing ovarian cancer

Also Published As

Publication number Publication date
CN103179977B (zh) 2016-10-26
US20130224233A1 (en) 2013-08-29
RU2586774C2 (ru) 2016-06-10
EP2608802B1 (en) 2017-02-22
BR112013004389A2 (pt) 2016-05-17
RU2013113639A (ru) 2014-10-10
WO2012026820A3 (en) 2012-06-21
CN103179977A (zh) 2013-06-26
EP2608802A2 (en) 2013-07-03
ES2621806T3 (es) 2017-07-05
CA2809153A1 (en) 2012-03-01
CA2809153C (en) 2023-09-26
WO2012026820A2 (en) 2012-03-01
US9295720B2 (en) 2016-03-29

Similar Documents

Publication Publication Date Title
IL276362A (en) Cancer treatment methods
HK1252832A1 (zh) 用於治療結腸直腸癌的方法
EP2558109A4 (en) METHOD FOR TREATING HARD TUMORS
EP2734207A4 (en) NEW COMPOSITIONS AND METHOD FOR THE TREATMENT OF PROSTATE CANCER
HK1181817A1 (en) Method for breast cancer recurrence prediction under endocrine treatment
ZA201205004B (en) Methods for treating pancreatic cancer
EP2643001A4 (en) METHOD OF TREATING CANCER
EP2635286A4 (en) METHOD FOR THE TREATMENT OF CANCER
HK1189272A1 (zh) 治療癌症的方法
IL228644A0 (en) Cancer treatment methods
EP2640383A4 (en) METHOD OF TREATING BREAST CANCER AND OVARIAN CANCER
EP2640390A4 (en) METHODS OF TREATING CANCER
IL218230A0 (en) Method of treating cancer
EP2632459A4 (en) METHOD OF TREATING NEUROENDOCRINE TUMORS
EP2560648A4 (en) METHOD OF TREATING PANCREATIC CANCER
PL2608802T3 (pl) Immunoterapeutyczny sposób leczenia raka gruczołu krokowego
EP2560639A4 (en) METHOD FOR THE TREATMENT OF PROSTATE CANCER
EP2538944A4 (en) METHOD FOR TREATING BRAIN TUMORS
PT2560638E (pt) Método de tratamento de cancro gástrico
EP2707011A4 (en) METHOD FOR THE TREATMENT OF PROSTATE CANCER
ZA201208905B (en) Cancer therapy method
GB201016382D0 (en) Process for treating an underground formation